SOPHiA GENETICS SA Sustainability Profile
SOPHiA GENETICS SA, a pioneering leader in the field of data-driven medicine, is headquartered in Switzerland (CH) and operates across Europe and North America. Founded in 2011, the company has made significant strides in the genomics industry, focusing on enhancing patient care through advanced analytics and artificial intelligence. Specialising in genomic data interpretation, SOPHiA GENETICS offers unique solutions that empower healthcare professionals to make informed decisions. Their flagship product, the SOPHiA DDM™ platform, stands out for its ability to integrate diverse data types, facilitating comprehensive insights into complex diseases. With a strong market position, SOPHiA GENETICS has been recognised for its innovative contributions to precision medicine, helping to transform the landscape of diagnostics and treatment. The company continues to drive advancements in genomic medicine, making a meaningful impact on patient outcomes worldwide.
DitchCarbon Score
How does SOPHiA GENETICS SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SOPHiA GENETICS SA's score of 31 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SOPHiA GENETICS SA's reported carbon emissions
SOPHiA GENETICS SA, headquartered in Switzerland (CH), has set ambitious climate commitments aimed at reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established significant reduction targets through the Science Based Targets initiative (SBTi). SOPHiA GENETICS commits to a 42% reduction in absolute Scope 2 greenhouse gas emissions by 2030, using 2024 as the base year. Additionally, the company aims to decrease Scope 3 emissions—covering areas such as purchased goods and services, capital goods, and business travel—by 51.6% per USD value added within the same timeframe. These targets are aligned with the necessary reductions to limit global warming to 1.5°C. The company's commitment to sustainability reflects its proactive approach within the healthcare technology sector, demonstrating a clear intention to mitigate its environmental impact while enhancing operational efficiency.
How Carbon Intensive is SOPHiA GENETICS SA's Industry?
How Carbon Intensive is SOPHiA GENETICS SA's Location?
SOPHiA GENETICS SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SOPHiA GENETICS SA has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
